Literature DB >> 73693

A new approach to the management of familial hypercholesterolaemia: Removal of plasma-cholesterol based on the principle of affinity chromatography.

P J Lupien, S Moorjani, J Awad.   

Abstract

Reduction of plasma-cholesterol by the removal of low-density lipoproteins (L.D.L.) in an extracorporeal system is described as a possible approach in the treatment of familial hypercholesterolaemia. L.D.L. were removed from the blood by their interaction with heparin linked to agarose beads in the presence of calcium ions. Plasma-L.D.L. was markedly decreased in two patients with heterozygous familial hypercholesterolaemia. The technique is specific for the removal of L.D.L., as the concentration of high-density lipoproteins was not affected. The treatment was well tolerated by all three subjects (i.e., two hypercholesterolaemic patients and a normal volunteer), and there were no undesirable effects. Several haematological parameters, clinical-chemistry tests, including serum enzymes, and immunoelectrophoresis of plasma proteins were all unaffected by the treatment.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 73693     DOI: 10.1016/s0140-6736(76)91736-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  15 in total

Review 1.  Incorporation of low-density lipoprotein apheresis into the treatment program of patients with severe hypercholesterolemia.

Authors:  B R Gordon
Journal:  Curr Atheroscler Rep       Date:  2000-07       Impact factor: 5.113

2.  In vivo regulation of human mononuclear leukocyte 3-hydroxy-3-methylglutaryl coenzyme A reductase. Decreased enzyme catalytic efficiency in familial hypercholesterolemia.

Authors:  P W Stacpoole; D M Bridge; I M Alvarez; R B Goldberg; H J Harwood
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

Review 3.  An update on LDL apheresis for nephrotic syndrome.

Authors:  Rupesh Raina; Vinod Krishnappa
Journal:  Pediatr Nephrol       Date:  2018-09-14       Impact factor: 3.714

Review 4.  Lipoprotein apheresis.

Authors:  Vijay G Bhoj; Bruce S Sachais
Journal:  Curr Atheroscler Rep       Date:  2015-07       Impact factor: 5.113

5.  Improved survival of patients with homozygous familial hypercholesterolaemia treated with plasma exchange.

Authors:  G R Thompson; J P Miller; J L Breslow
Journal:  Br Med J (Clin Res Ed)       Date:  1985-12-14

6.  Suitable hollow fibre immunobioreactors for specific ex vivo removal of antibodies and antigens from plasma.

Authors:  C Larue; V Gueraud; C Rivat
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

7.  Low-density lipoprotein plasmaphaeresis with and without lovastatin in the treatment of the homozygous form of familial hypercholesterolaemia.

Authors:  J Thiery; A K Walli; G Janning; D Seidel
Journal:  Eur J Pediatr       Date:  1990-07       Impact factor: 3.183

8.  Preparation of heparin-immobilized PVA and its adsorption for low-density lipoprotein from hyperlipemia plasma.

Authors:  Kai-Wang Ma; Li Ma; Shao-Xi Cai; Xiang Wang; Bin Liu; Zhi-Ling Xu; Xiao-Zhen Dai; Jian-Ying Yang; Ai-Hua Jing; Wan-Jun Lei
Journal:  J Mater Sci Mater Med       Date:  2008-05-13       Impact factor: 3.896

Review 9.  Artificial liver. State of the art.

Authors:  T Takahashi; P S Malchesky; Y Nosé
Journal:  Dig Dis Sci       Date:  1991-09       Impact factor: 3.199

10.  Selective removal of apolipoprotein B-containing serum lipoproteins from blood plasma.

Authors:  W Stoffel; T Demant
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.